Literature DB >> 17664553

Geometric uncertainty of 2D projection imaging in monitoring 3D tumor motion.

Yelin Suh1, Sonja Dieterich, Paul J Keall.   

Abstract

The purpose of this study was to investigate the accuracy of two-dimensional (2D) projection imaging methods in three-dimensional (3D) tumor motion monitoring. Many commercial linear accelerator types have projection imaging capabilities, and tumor motion monitoring is useful for motion inclusive, respiratory gated or tumor tracking strategies. Since 2D projection imaging is limited in its ability to resolve the motion along the imaging beam axis, there is unresolved motion when monitoring 3D tumor motion. From the 3D tumor motion data of 160 treatment fractions for 46 thoracic and abdominal cancer patients, the unresolved motion due to the geometric limitation of 2D projection imaging was calculated as displacement in the imaging beam axis for different beam angles and time intervals. The geometric uncertainty to monitor 3D motion caused by the unresolved motion of 2D imaging was quantified using the root-mean-square (rms) metric. Geometric uncertainty showed interfractional and intrafractional variation. Patient-to-patient variation was much more significant than variation for different time intervals. For the patient cohort studied, as the time intervals increase, the rms, minimum and maximum values of the rms uncertainty show decreasing tendencies for the lung patients but increasing for the liver and retroperitoneal patients, which could be attributed to patient relaxation. Geometric uncertainty was smaller for coplanar treatments than non-coplanar treatments, as superior-inferior (SI) tumor motion, the predominant motion from patient respiration, could be always resolved for coplanar treatments. Overall rms of the rms uncertainty was 0.13 cm for all treatment fractions and 0.18 cm for the treatment fractions whose average breathing peak-trough ranges were more than 0.5 cm. The geometric uncertainty for 2D imaging varies depending on the tumor site, tumor motion range, time interval and beam angle as well as between patients, between fractions and within a fraction.

Entities:  

Mesh:

Year:  2007        PMID: 17664553     DOI: 10.1088/0031-9155/52/12/008

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  7 in total

1.  Registration of clinical volumes to beams-eye-view images for real-time tracking.

Authors:  Jonathan H Bryant; Joerg Rottmann; John H Lewis; Pankaj Mishra; Paul J Keall; Ross I Berbeco
Journal:  Med Phys       Date:  2014-12       Impact factor: 4.071

2.  Accuracy in the localization of thoracic and abdominal tumors using respiratory displacement, velocity, and phase.

Authors:  U W Langner; P J Keall
Journal:  Med Phys       Date:  2009-02       Impact factor: 4.071

3.  Beam's-eye-view imaging during non-coplanar lung SBRT.

Authors:  Stephen S F Yip; Joerg Rottmann; Ross I Berbeco
Journal:  Med Phys       Date:  2015-12       Impact factor: 4.071

4.  A deliverable four-dimensional intensity-modulated radiation therapy-planning method for dynamic multileaf collimator tumor tracking delivery.

Authors:  Yelin Suh; Elisabeth Weiss; Hualiang Zhong; Mirek Fatyga; Jeffrey V Siebers; Paul J Keall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-08-01       Impact factor: 7.038

5.  On the accuracy of a moving average algorithm for target tracking during radiation therapy treatment delivery.

Authors:  Rohini George; Yelin Suh; Martin Murphy; Jeffrey Williamson; Elizabeth Weiss; Paul Keall
Journal:  Med Phys       Date:  2008-06       Impact factor: 4.071

6.  Stochastic rank correlation: a robust merit function for 2D/3D registration of image data obtained at different energies.

Authors:  Wolfgang Birkfellner; Markus Stock; Michael Figl; Christelle Gendrin; Johann Hummel; Shuo Dong; Joachim Kettenbach; Dietmar Georg; Helmar Bergmann
Journal:  Med Phys       Date:  2009-08       Impact factor: 4.071

7.  Monitoring tumor motion by real time 2D/3D registration during radiotherapy.

Authors:  Christelle Gendrin; Hugo Furtado; Christoph Weber; Christoph Bloch; Michael Figl; Supriyanto Ardjo Pawiro; Helmar Bergmann; Markus Stock; Gabor Fichtinger; Dietmar Georg; Wolfgang Birkfellner
Journal:  Radiother Oncol       Date:  2011-08-30       Impact factor: 6.280

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.